Skip to content
Aviation, Medical Health Aged Care

Metakosmos® Unveils “Kosmosuit Kernel360(TM)” – First of its Kind Spacesuit Telemetry & Human Performance Software

Metakosmos 3 mins read

[Sydney, New South Wales] - [07/10/2024]

Metakosmos launches, Kosmosuit Kernel360™, pioneering commercial software, for spacesuit & bioastronautics intelligence. This cutting-edge software aims to redefine how astronauts are trained, while also applicable to operators within extreme conditions across land, sea & air.

Drawing on the latest advancements in space technology, real-time operations, digital twins & suit telemetry, Metakosmos has engineered a software solution that replicates the dynamic and challenging conditions of space flight within a virtual training environment. Leveraging state-of-the-art simulations, advanced algorithms, real-time suit telemetry and immersive experiences, this software offers unparalleled training opportunities for students, researchers, flight surgeons, astronaut cadets, career astronauts & pilots across the globe.

Key features of Kosmosuit®Kernel360™ include:

Multi-planetary Simulation: Astronauts & pilots can now experience the complexities of human space flight with unparalleled realism, from zero-gravity environments to orbital manoeuvres and docking procedures.

Applied Biomechanics: The software employs proprietary learning algorithms to tailor training & performance experiences to individual astronaut & pilot needs, ensuring optimal skill development and proficiency.

Suit Telemetry: Suit users can engage in a wide range of scenario-based training exercises, preparing them for a diverse array of challenges encountered in space missions & extreme environments on land, sea & air through real-time telemetry.

Suit Digital Twins: Customisable suit digital twins with invaluable insights into user performance, facilitating targeted feedback and continuous improvement before operating on real-world assets.

Cost-Efficiency: By simulating human spaceflight missions with a connected suit & telemetry platform, the software significantly reduces the costs associated with traditional astronaut training methods, human resources, infrastructure needs, data discrepancies & capital equipment.

Commenting on the significance of this technological breakthrough, CEO Kiriti Rambhatla of Metakosmos stated that, "Our team is thrilled to unveil this revolutionary software, which represents a major milestone in the evolution of commercial human spaceflight life cycle. By harnessing the power of our proprietary technology, we aim to empower users with the skills and confidence needed to navigate the challenges of modern spaceflight. The tool is also of value to extreme operators across land, sea & air”.

In recognition of its transformative potential, the software’s beta version has already garnered acclaim from industry experts and space professionals alike, winning the prestigious Australian Good Design Award 2024. 

Kernel360 is being developed further with support provided by the Australian Space Agency's Moon to Mars Supply Chain Capability Improvement Grant. This has been instrumental in accelerating innovation and empowering the company to make bold strides toward commercial human spaceflight services. The tool will be deployed at the Responsive Space Operations Centre, Adelaide for beta testing.

Dr James Elliott of Kolling Institute, which is one of the oldest medical research institutions in Australia and a beta testing partner said, “By leveraging the combined multidisciplinary expertise of Metakosmos and Researchers from the Kolling and INSIGHT, among other institutions, we are breaking new collaborative ground in wearable technology for extreme environments, marking a significant step forward in human health and performance on Earth and beyond.” 

The tool has a modular open architecture allowing it to adapt to other industrial segments through integration to third party applications. Alazadhar Al-Sanai a leading Saudi Arabian real time operations company is partnering through its environmental intelligence application.

With its unparalleled realism, adaptability, and cost-efficiency, it is poised to become the gold standard in human spaceflight life cycle monitoring.


Key Facts:

 

 


About us:

Metakosmos is dedicated to pushing the boundaries of space technology. Based in Sydney Australia, the company focuses on developing innovative solutions and extreme environment suits, that address the most pressing challenges in human spaceflight. With a team of experienced engineers, medical doctors and scientists, Metakosmos aims to transform the accessibility of the human spaceflight lifecycle. Metakosmos won several Australian Government Grants and global Awards for its engineering and innovation approach. Stay connected to our Spacesuit development journey at www.metakosmos.com.au and follow us on our social media channels (Twitter, Facebook, LinkedIn, YouTube).


Contact details:

Metakosmos
info@metakosmos.com.au
www.metakosmos.com.au

Media

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.